maziar mike doustdar - Search News

News

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to revive sales and a share price hit by worries the maker of weight-loss drug Wegovy is falling behind in a race it started.

The Wall Street Journal on MSN · 8h

Can Novo Nordisk’s New CEO Stop Rivals From Taking Over the Anti-Obesity Market?

Danish leader will face a challenging landscape among competitors

Fast Company on MSN · 2d

NVO stock: Why did Novo Nordisk shares drop 20% today—and who is Maziar Mike Doustdar?

The GLP-1 weight-loss drug giant just cut its investor guidance for 2025. Could the boom be over? Health-related stocks are not having a good day. First, America’s largest health insurance provider, UnitedHealth Group (NYSE: UNH),

2don MSN

Wegovy maker Novo's profit warning triggers $70 billion share rout

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...

2don MSN

Novo Lifer Takes Job of Reviving Europe’s Weight-Loss Superstar

Maziar Mike Doustdar spent more than three decades quietly climbing the ranks of Novo Nordisk A/S, from office clerk through ...

Devdiscourse2d

Novo Nordisk Announces New CEO Amidst Weight-Loss Drug Competition

Novo Nordisk appoints Maziar Mike Doustdar as the new CEO to tackle falling sales and shares amid stiff competition in the ...

The Copenhagen Post1d

An international is the new CEO of Danish largest company: “I have embraced the Danish spirit, but we know no borders”

It’s not unusual for a non-national to be CEO, executive director, or president of a company in a country. “C-level” positions and top management roles are often international. However, when the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results